HRS 1780
Alternative Names: HRS-1780Latest Information Update: 09 Aug 2024
At a glance
- Originator Shandong Suncadia Medicine
- Class Mineralocorticoids; Urologics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Renal failure
Most Recent Events
- 18 Jul 2024 Shandong Suncadia Medicine plans a phase I trial for Type 2 diabetes mellitus (In Volunteers) in China (PO) in July 2024 (NCT06495931)
- 02 Mar 2024 Phase-II clinical trials in Renal failure (Treatment-experienced) in China (PO) (NCT06221059)
- 24 Jan 2024 Shandong Suncadia Medicine plans a phase II trial for Renal failure (PO, Tablet) in April 2024 (NCT06221059)